Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 376-400 of 606 matching filings.

Per page
25
Current page
16
6-K File 001-36421

6-K

Filing date
12 Dec 2019
Reporting date
12 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88628

SC 13D/A

Filing date
10 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-222413

PROSPECTUS SUPPLEMENT NO. 4

Filing date
10 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
10 Dec 2019
Reporting date
10 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-222413

PROSPECTUS SUPPLEMENT NO. 4

Filing date
09 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
09 Dec 2019
Reporting date
09 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88628

SC 13D/A

Filing date
09 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88628

SC 13D/A

Filing date
06 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
06 Dec 2019
Reporting date
04 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
04 Dec 2019
Reporting date
03 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
14 Nov 2019
Reporting date
30 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
14 Nov 2019
Reporting date
14 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88628

SC 13D/A

Filing date
13 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
13 Nov 2019
Reporting date
13 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
07 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
31 Oct 2019
Reporting date
31 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
16 Oct 2019
Reporting date
16 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88628

SCHEDULE 13G

Filing date
25 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
13 Sep 2019
Reporting date
13 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-233765

S-8

Filing date
13 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-222413

PROSPECTUS SUPPLEMENT NO. 3

Filing date
13 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
06 Aug 2019
Reporting date
30 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
06 Aug 2019
Reporting date
06 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
18 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
27 Jun 2019
Reporting date
26 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .